Cloud Banner

Healthcare

Image

Global Microfluidics Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Microfluidics Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 15.01% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 23.17 Billion
Diagram Market Size (Forecast Year) USD 70.93 Billion
Diagram CAGR 15.01%

Global Microfluidics Market, By Product Type (Microfluidic-based devices and Microfluidic Components), Material (Polymer, Glass, Silicon, Metal, Ceramics, PDMS, Other), Technology (Medical/Healthcare, Non-medical), Application (In Vitro diagnostics, Point-of-Care Testing, Clinical Diagnostics, Pharmaceutical Research, Lab Analytics, Microdispensing, Microreaction, Drug Delivery, Laboratory Testing, Analytical Testing, High Throughput Screening), Sector (Industrial, Healthcare, In-vitro Diagnostics, Environmental Research, Clinical Diagnostics), End User (Hospitals and Diagnostic Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies) – Industry Trends and Forecast to 2030.

Microfluidics Market

Microfluidics Market Analysis and Size

According to GLOBOCAN 2020, there were 19,282,789 new cancer cases worldwide in 2020, with a projected increase to 28,887,940 cases by 2040. As a result, global cancer incidence and modern healthcare facilities have been major drivers of market growth. ​​Furthermore, market participants have broadened their diagnostic platforms to include POC on microfluidic devices. As a result of the expansion of the range of POC diagnostics, there will be a significant expansion in microfluidics, which may enable the development of new devices.

Data Bridge Market Research analyses that the microfluidics market which was USD 23.17 billion in 2022, is expected to reach USD 70.93 billion by 2030, at a CAGR of 15.01% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Microfluidics Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Microfluidic-based devices and Microfluidic Components), Material (Polymer, Glass, Silicon, Metal, Ceramics, PDMS, Other), Technology (Medical/Healthcare, Non-medical), Application (In Vitro diagnostics, Point-of-Care Testing, Clinical Diagnostics, Pharmaceutical Research, Lab Analytics, Microdispensing, Microreaction, Drug Delivery, Laboratory Testing, Analytical Testing, High Throughput Screening), Sector (Industrial, Healthcare, In-vitro Diagnostics, Environmental Research, Clinical Diagnostics), End User (Hospitals and Diagnostic Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), BD (U.S.), Illumina, Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), Fluidigm Corporation (U.S.), Dolomite Microfluidics (U.K.), QIAGEN (Germany) Abbott (U.S.), BIOMÉRIEUX (France), microfluidic ChipShop GmbH (Germany), Elveflow (France), Cellix Bio. (India), Micronit B.V. (Netherlands), PARKER HANNIFIN CORP (U.S.) and Fortive (U.S.)

Market Opportunities

  • Development of new products

Market Definition

Microfluidics is a technological method used to investigate the nature and characteristics of fluids. Its application entails the use of a set of tools for manipulating and controlling the chemical and biological processes of small volumes of fluids. It is also used in the production of microminiaturized devices with numerous tunnels and chambers through which fluids flow or are confined. In comparison to traditional fluid measuring devices, it requires fewer samples, the tools are smaller, and it provides excellent parameter control and data quality. As a result, it's commonly used for DNA analysis, cell separation and manipulation, and PCR amplification.

Global Microfluidics Market Dynamics

Drivers

  • Increased the demand for microfluidics tools

The global increase in COVID-19 cases has increased the demand for microfluidics tools. PCR is used in many approved tests, making it a preferred technique for COVID-19 diagnosis. To combat the increasing number of COVID-19 cases worldwide, several manufacturers have introduced products and increased production to meet the growing demand for IVD tests. When combined with microfluidics, the PCR technique can be accelerated, resulting in faster test results with high accuracy (from approximately 1 hour to less than 10 minutes). For instance, BeforCure, an Elvesys spin-off company, developed an ultra-fast PCR-on-chip system for virus detection. This product is based on Fastgen technology and takes advantage of microfluidics to provide test results in less than 30 minutes. Moreover, several studies are being conducted to evaluate the use of microfluidics in COVID-19 detection via PCR. These are the certain factors which help the market to grow.

  • Rise in demand of Point-of-care diagnostics (POC)

Point-of-care diagnostics (POC) is believed to be an important part of healthcare, particularly in disease diagnosis. Microfluidics technology is ideal for point-of-care diagnostics. This technology has the potential to provide rapid and affordable point-of-care diagnostic tools to aid in the COVID-19 pandemic. The demand for point-of-care molecular diagnostics is expected to increase in the future because point-of-care diagnostics enable the early detection of disease.

Opportunities

  • Development of new products

In March 2021, the Loschmidt laboratories team collaborated with ETH Zurich partners to create a microfluidic platform to effectively and rapidly investigate enzymes and their properties. The novel platform was already being used to develop new thrombolytics for stroke treatment and to study the evolution of bioluminescent enzymes. Furthermore, in November 2019, Panasonic Corporation and IMT collaborated to develop a technology for mass production of microfluidic devices using glass moulding. When compared to traditional glass etching techniques, this technology employs low-cost, high-accuracy mass production. These devices can be used for analysis and sensing in biological, environmental, and medical applications, and thus are expected to drive the microfluidics market during the forecast period.

Restraints/Challenges

  • Strict regulatory approvals

The standardization/commercialization of microfluidic devices may pose additional challenges to the market's future growth. The complex and difficult regulatory approval process, on the other hand, is expected to stymie the growth of the microfluidics market during the forecast period.

This microfluidics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the microfluidics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Microfluidics Market

The COVID-19 epidemic had a favourable influence on the microfluidics market. Rapid diagnostic tests, point-of-care diagnostics, and IVD devices that use microfluidic technology for drug discovery and COVID-19 testing were in high demand. To diagnose COVID-19, several industry participants were concentrating on introducing rapid antigen testing based on microfluidics technology. Regulatory agencies had also pledged their assistance for the approval of microfluidics testing to battle the pandemic. As a result, the microfluidics business had seen both good and bad consequences, and major players had made strategic decisions to deal with the situation. Microfluidics kits were expected to be in more demand as the number of rapid diagnostic tests, point-of-care testing, and IVD devices grow, ensuring the accuracy and precision of patients' sample results. As the recovery began in 2021, large firms began reclaiming their positions through production growth and capacity utilization while adhering to the COVID-19 protocols. However, the market is expected to show a steady recovery and relative increase in the future.

Recent Developments

  • In 2021, Fluidigm launched its new Biomark X microfluidics platform. Biomark X streamlines operations to reduce hands-on time and speeds up results with more data per run.
  • In 2021, SCHOTT agreed to buy Applied Microarrays Inc., a microarray solutions company based in Arizona. This will strengthen the company's presence in the United States as well as its bioscience capabilities.

Global Microfluidics Market Scope

The microfluidics market is segmented on the basis of product type, material, technology, application, sector and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Microfluidic-based devices
  • Microfluidic Components
  • Microfluidic chips
  • Flow and pressure sensors
  • Flow and pressure controllers
  • Microfluidic valves
  • Micropumps
  • Microneedles
  • Components

 Material

  • Polymer
  • Glass
  • Silicon
  • Metal
  • Ceramics
  • PDMS
  • Other

 Technology

  • Medical/Healthcare
  • Non-medical

 Application

  • In Vitro diagnostics
  • Clinical diagnostics
  • Point-of-care testing
  •  Veterinary diagnostics
  • Point-of-Care Testing
  • Clinical Diagnostics
  • Pharmaceutical Research
  • Lab Analytics
  • Proteomics
  • Genomics
  • Cell-based assays
  • Capillary electrophoresis
  • Microdispensing
  • Microreaction
  • Drug Delivery
  • Laboratory Testing
  • Analytical Testing
  • High Throughput Screening

 Sector

  • Industrial
  • Healthcare
  • In-vitro Diagnostics
  • Environmental Research
  • Clinical Diagnostics

 End User

  • Hospitals and Diagnostic Centers
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies

Microfluidics Market Regional Analysis/Insights

The microfluidics market is analyzed and market size insights and trends are provided by country, product type, material, technology, application, sector and end user as referenced above.

The countries covered in the microfluidics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the microfluidics market due to research institutions' extensive involvement in the development of novel microfluidic devices.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the government's increased support for developed infrastructure and robust intellectual property ownership.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The microfluidics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for microfluidics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the microfluidics market. The data is available for historic period 2011-2021.

Competitive Landscape and Microfluidics Market Share Analysis

The microfluidics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to microfluidics market.

Some of the major players operating in the microfluidics market are:

  • Danaher (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • PerkinElmer Inc. (U.S.)
  • Agilent Technologies Inc. (U.S.)
  • Bio-Rad Laboratories Inc. (U.S.)
  • BD (U.S.)
  • Illumina, Inc. (U.S.)
  • F. Hoffmann-La Roche (Switzerland)
  • Fluidigm Corporation (U.S.)
  • Dolomite Microfluidics (U.K.)
  • QIAGEN (Germany)
  • Abbott (U.S.)
  • BIOMÉRIEUX (France)
  • microfluidic ChipShop GmbH (Germany)
  • Elveflow (France)
  • Cellix Bio. (India)
  • Micronit B.V. (Netherlands)
  • PARKER HANNIFIN CORP (U.S.)
  • Fortive (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The microfluidics market size will be worth USD 70.93 billion by 2030.
The growth rate of the microfluidics market is 15.01% in the forecast by 2030.
Increased demand for microfluidics tools & rise in demand for point-of-care diagnostics (POC) are the growth drivers of the microfluidics market.
Product type, material, technology, application, sector, and end-user are the factors on which microfluidics market research is based.
Major companies in the Africa rapid diagnostic tests (RDT) market are Danaher (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), BD (U.S.), Illumina, Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), Fluidigm Corporation (U.S.), Dolomite Microfluidics (U.K.), QIAGEN (Germany) Abbott (U.S.), BIOMÉRIEUX (France), microfluidic ChipShop GmbH (Germany), Elveflow (France), Cellix Bio. (India), Micronit B.V. (Netherlands), PARKER HANNIFIN CORP (U.S.) and Fortive (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials